...
首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
【24h】

Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.

机译:使用编码HA-1的cDNA逆转录转导的树突状细胞有效诱导次要组织相容性抗原HA-1特异性细胞毒性T细胞。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cytotoxic T-cells (CTLs) specific for the hematopoietic system-restricted minor histocompatibility antigen (mHag) HA-1 efficiently lyse HA-1-positive leukemic cells without affecting nonhematopoietic cells. HA-1-specific CTLs are thus potential tools for adoptive immunotherapy of relapsed leukemia after HLA-matched-HA-1-mismatched stem cell transplantation (SCT). In vitro generation of HA-1-specific CTLs from SC donors is possible using dendritic cells (DCs) pulsed with synthetic HA-1 peptide as stimulator cells. However, this approach requires at least 6 weeks of in vitro culturing under GMP (good manufacturing practice) conditions. Our data show that in vitro induction of HA-1-specific CTLs is more rapid with the use of DCs that are retrovirally transduced with the HA-1 complementary DNA. Retrovirally transduced DCs showed functional and long-term stable expression of the HA-1 CTL epitope in primary CTL cultures. In 4 SC donors, HA-1-transduced DCs induced HA-1-specific CTLs in 14 to 21 days. The in vitro-generated CTL lines contained 6% to 9% T-cells that stained brightly with tetrameric HLA-A2/HA-1 peptide complexes (HA-1(A2) tetramer) and showed significant lysis of HA-1+ leukemic cells. The CTL induction procedure using peptide-pulsed DCs was less effective and required 28 to 35 days of T-cell culture. Thus, sustained presentation of mHag HA-1 by retrovirally transduced DCs facilitates the in vitro induction of HA-1-specific CTLs.
机译:对造血系统限制的次要组织相容性抗原(mHag)HA-1特异的细胞毒性T细胞(CTL)可有效裂解HA-1阳性白血病细胞,而不会影响非造血细胞。因此,HA-1特异性CTL是HLA匹配HA-1不匹配干细胞移植(SCT)后对复发性白血病进行过继免疫治疗的潜在工具。使用以合成HA-1肽脉冲的树突状细胞(DC)作为刺激细胞,可以从SC供体体外生成HA-1特异性CTL。但是,此方法需要在GMP(良好生产规范)条件下进行至少6周的体外培养。我们的数据表明,使用通过HA-1互补DNA逆转录病毒转导的DC,在体外诱导HA-1特异的CTL更快。逆转录病毒转导的DC在原代CTL培养物中显示HA-1 CTL表位的功能性和长期稳定表达。在4个SC供体中,HA-1转导的DC在14到21天内诱导了HA-1特异性CTL。体外生成的CTL系包含6%至9%的T细胞,这些细胞被四聚体HLA-A2 / HA-1肽复合物(HA-1(A2)四聚体)明亮地染色,并显示出HA-1 +白血病细胞的显着裂解。使用肽脉冲DC的CTL诱导程序效果较差,需要T细胞培养28至35天。因此,逆转录病毒转导的DC持续呈递mHag HA-1有助于体外诱导HA-1特异性CTL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号